Publications
A Brief Overview of the Examination Practice of "Same-Day Dual Filing" Applications in China
The newly revised Examination Guidelines (2023 version) (hereinafter referred to
China’s Confidentiality Examination Requirement in Cross-Border R&D —Guidance from the Supreme Peopl...
Zunxia Li, Partner of IP MarchThe Supreme People’s Court of China (SPC) recently
Recently Published SPC Judgment Clarifies the Continued Viability of the “Straw Man” Strategy in Chi...
Zunxia Li, Partner of IP March BackgroundArticle 45 of the Patent Law of the PRC
The Pharmaceutical Patent Term Extension System in China – An Overview with Case Studies
Ms. Wei Yang, Partner, IP March The pharmaceutical industry is among the most he
Trademark Law Revision: Key Changes at a Glance
The newly revised Chinese Trademark Law has recently been promulgated and will t
CNIPA released newly revised rules and requirements for trademark non-use cancellations
In recent times, issues surrounding the cancellation of registered trademarks fo
Insights and Considerations from the invalidation case as to Ruxolitinib
Ruxolitinib, a selective JAK1/JAK2 inhibitor developed by Incyte Corporation, wo
Definition and Acceptable Conditions for “Disclaimer Amendment” from the Second-Instance Judgment of...
Introduction“Disclaimer amendment” refers to a manner of claim amendment to excl
Protecting consumer interests in trademark examinations
In the examination and trial of trademarks, consumers as the key participants in
Exploration of Graphical Representation for Partial Design
——Strategies for forming a relatively independent area and constituting a relati